Dimebon Dimebolin Information Availability
If you're new here, you may want to subscribe to my RSS feed. Thanks for visiting!
Dimebom is a new pharmaceutical treatment alternative for patients suffering from Alzheimer’s Disease. Dimebon is an older medication that has recently been discovered to be most helpful in treating patients with Alzheimer’s Disease . Dimebon ( the actual drug is known chemically as Dimebolin) is an older Russian antihistamine drug. It was popularly used in Russia as an antihistamine for hayfever , allergies and the like. In fact the drug was sold as an easy to obtain antihistamine – sold over the counter without a prescription.
Dimebon is currently in clinical trials in the United States by a company named Medivation The website for Medivation , the pharmaceutical company involved with the clinical development and testing of Dimebon in the United States can be found at link www.medivation.com . To learn more about Medivation’s clinical trials of Dimebon the link is
http://www.medivation.com/pipeline_dimebontrials.html#p3
For more information on CONNECTION study locations, eligibility and enrollment, please visit www.connectionstudy.com or call toll-free 1-877-888-6386
At this point in time Dimebon is not available in any manner to Alzheimer Patients or their families , outside of the study material afforded by the Medivation company and the Medivation clinical trials themselves.
please post message re:intositepromo in send to:
My name is Dave
I was originally a patient/subject for PET scan in year 2000 at Columbia Presbyterian Medical Center seeking any results for
Alzheimerms and/or Depression.
Medically stated results showed no injury.
A severe/trauma related brain injury (TBI) revealed incidentally a cerebral aneurysm in the anterior commmunicating artery in July 2004, whereby I submitted to surgical intervention by Dr.Song at St. Lukes
Hospital’s Center For Endovascular Surgery in November 2004.
Subsequent hospitalization in October/November 2007 at Mt.Sinai Hospital (NYC location) revealed a previously missed stroke. A 2nd stroke occurred in July 2008 and was notated at Metropolitan Hospital (August 2008). Concurrent use of Aricept from 2005 to 2008 was administered by neurologist, New Port Richey, FL and neurology at Metropolitan Hospital, despite Dr. Koeppel there, who transferred admininstration of Aricept to psych. dept at Metropolitan at NYC.
Subsequently used the internet to network with biochemistry depts. at several colleges, including “Dr.Dave” Nichols at Purdue University.
I then, at my own conclusion discontinued Aricept, though I had no side-effects that I noticed.
I am interested in using concurrent administration of Medivation and Aricept in conjunction with or without “cocktail #39″.
Thank you for your attention to this very serious inquiry of mine,
as I seek healing while my intelligence (documented high IQ) continues to dwindle, as I now just read XML/HTML source code for scienblog.com relating to the stated medical “?” news that highy educated individual Alzheimers positive patients show elevated Alzheimer’s related brain damage?
Sincerely,
Davd